Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases

被引:20
|
作者
Swaddiwudhipong, Nol [1 ,2 ]
Whiteside, David J. [1 ,2 ]
Hezemans, Frank H. [1 ,3 ]
Street, Duncan [1 ]
Rowe, James B. [1 ,2 ,3 ]
Rittman, Timothy [1 ,2 ]
机构
[1] Dept Clin Neurosci, Herchel Smith Bldg,Robinson Way, Cambridge CB2 0SZ, England
[2] Univ Cambridge, Cambridge Univ Hosp NHS Trust, Cambridge, England
[3] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England
关键词
Alzheimer's disease; cognition; dementia; dementia with Lewy bodies; frontotemporal dementia; multiple system atrophy; neurodegenerative disease; Parkinson disease; physical function; pre-diagnostic; progressive supranuclear palsy; sporadic; UK Biobank; FALSE DISCOVERY RATE; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; SYSTEM ATROPHY; R PACKAGE; DIAGNOSIS; BETA; TAU;
D O I
10.1002/alz.12802
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The pathophysiological processes of neurodegenerative diseases begin years before diagnosis. However, pre-diagnostic changes in cognition and physical function are poorly understood, especially in sporadic neurodegenerative disease. Methods UK Biobank data were extracted. Cognitive and functional measures in individuals who subsequently developed Alzheimer's disease (AD), Parkinson disease, frontotemporal dementia, progressive supranuclear palsy, dementia with Lewy bodies, or multiple system atrophy were compared against individuals without neurodegenerative diagnoses. The same measures were regressed against time to diagnosis, after adjusting for the effects of age. Results There was evidence for pre-diagnostic cognitive impairment and decline with time, particularly in AD. Pre-diagnostic functional impairment and decline were observed in multiple diseases. Discussion The scale and longitudinal follow-up of UK Biobank participants provides evidence for cognitive and functional decline years before symptoms become obvious in multiple neurodegenerative diseases. Identifying pre-diagnostic functional and cognitive changes could improve selection for preventive and early disease-modifying treatment trials.
引用
收藏
页码:1752 / 1763
页数:12
相关论文
共 50 条
  • [11] Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia
    Adams, Hieab H. H.
    de Bruijn, Renee F. A. G.
    Hofman, Albert
    Uitterlinden, Andre G.
    van Duijn, Cornelia M.
    Vernooij, Meike W.
    Koudstaal, Peter J.
    Ikram, M. Arfan
    ALZHEIMERS & DEMENTIA, 2015, 11 (11) : 1277 - 1285
  • [12] Common pre-diagnostic features in individuals with different rare diseases represent a key for diagnostic support with computerized pattern recognition?
    Grigull, Lorenz
    Mehmecke, Sandra
    Rother, Ann-Katrin
    Bloess, Susanne
    Klemann, Christian
    Schumacher, Ulrike
    Muecke, Urs
    Kortum, Xiaowei
    Lechner, Werner
    Klawonn, Frank
    PLOS ONE, 2019, 14 (10):
  • [13] Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses
    Dilliott, Allison A.
    Sunderland, Kelly M.
    McLaughlin, Paula M.
    Roberts, Angela C.
    Evans, Emily C.
    Abrahao, Agessandro
    Binns, Malcolm A.
    Black, Sandra E.
    Borrie, Michael
    Casaubon, Leanne K.
    Dowlatshahi, Dar
    Finger, Elizabeth
    Fischer, Corinne E.
    Frank, Andrew
    Freedman, Morris
    Grimes, David
    Hassan, Ayman
    Jog, Mandar
    Kumar, Sanjeev
    Kwan, Donna
    Lang, Anthony E.
    Mandzia, Jennifer
    Marras, Connie
    Masellis, Mario
    McIntyre, Adam D.
    Pasternak, Stephen
    Pollock, Bruce G.
    Rajji, Tarek K.
    Robinson, John F.
    Rogaeva, Ekaterina
    Sahlas, Demetrios J.
    Saposnik, Gustavo
    Sato, Christine
    Seitz, Dallas
    Shoesmith, Christen
    Steeves, Thomas
    Strother, Stephen C.
    Swartz, Richard H.
    Tan, Brian
    Tang-Wai, David
    Tartaglia, Maria C.
    Troyer, Angela K.
    Turnbull, John
    Zinman, Lorne
    Hegele, Robert A.
    NEUROBIOLOGY OF AGING, 2021, 105 : 378.e1 - 378.e9
  • [14] Adult Hippocampal Neurogenesis, Aging and Neurodegenerative Diseases: Possible Strategies to Prevent Cognitive Impairment
    Vivar, Carmen
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (21) : 2175 - 2192
  • [15] Functional MRI in investigating cognitive impairment in multiple sclerosis
    Rocca, M. A.
    De Meo, E.
    Filippi, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 134 : 39 - 46
  • [16] Cognitive Impairment and Neurodegenerative Diseases Development Associated with Organophosphate Pesticides Exposure: a Review Study
    Sarailoo, Mehdi
    Afshari, Salva
    Asghariazar, Vahid
    Safarzadeh, Elham
    Dadkhah, Masoomeh
    NEUROTOXICITY RESEARCH, 2022, 40 (05) : 1624 - 1643
  • [17] Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases
    Mogi, Masaki
    Horiuchi, Masatsugu
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2013, 13 (01) : 13 - 18
  • [18] Cognitive Impairment and Neurodegenerative Diseases Development Associated with Organophosphate Pesticides Exposure: a Review Study
    Mehdi Sarailoo
    Salva Afshari
    Vahid Asghariazar
    Elham Safarzadeh
    Masoomeh Dadkhah
    Neurotoxicity Research, 2022, 40 : 1624 - 1643
  • [19] The Smart Aging Platform for Assessing Early Phases of Cognitive Impairment in Patients With Neurodegenerative Diseases
    Bottiroli, Sara
    Bernini, Sara
    Cavallini, Elena
    Sinforiani, Elena
    Zucchella, Chiara
    Pazzi, Stefania
    Cristiani, Paolo
    Vecchi, Tomaso
    Tost, Daniela
    Sandrini, Giorgio
    Tassorelli, Cristina
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [20] Glutamatergic Neurotransmission in Aging and Neurodegenerative Diseases: A Potential Target to Improve Cognitive Impairment in Aging
    Castillo-Vazquez, Selma Karime
    Massieu, Lourdes
    Rincon-Heredia, Ruth
    Garcia-delaTorre, Paola
    Quiroz-Baez, Ricardo
    Gomez-Verjan, Juan Carlos
    Rivero-Segura, Nadia Alejandra
    ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (06)